nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ABCB1—Mitomycin—stomach cancer	0.224	0.581	CbGbCtD
Terazosin—ABCB1—Irinotecan—stomach cancer	0.0575	0.149	CbGbCtD
Terazosin—ABCB1—Docetaxel—stomach cancer	0.0422	0.109	CbGbCtD
Terazosin—ABCB1—Doxorubicin—stomach cancer	0.0314	0.0815	CbGbCtD
Terazosin—ABCB1—Methotrexate—stomach cancer	0.0304	0.0789	CbGbCtD
Terazosin—Prazosin—HTR1A—stomach cancer	0.00186	1	CrCbGaD
Terazosin—Sinusitis—Epirubicin—stomach cancer	0.000588	0.00126	CcSEcCtD
Terazosin—Diarrhoea—Irinotecan—stomach cancer	0.000586	0.00126	CcSEcCtD
Terazosin—Dry mouth—Capecitabine—stomach cancer	0.000585	0.00125	CcSEcCtD
Terazosin—Shock—Docetaxel—stomach cancer	0.000583	0.00125	CcSEcCtD
Terazosin—Pruritus—Fluorouracil—stomach cancer	0.000581	0.00124	CcSEcCtD
Terazosin—Thrombocytopenia—Docetaxel—stomach cancer	0.00058	0.00124	CcSEcCtD
Terazosin—Visual impairment—Methotrexate—stomach cancer	0.000579	0.00124	CcSEcCtD
Terazosin—Confusional state—Capecitabine—stomach cancer	0.000578	0.00124	CcSEcCtD
Terazosin—Tachycardia—Docetaxel—stomach cancer	0.000578	0.00124	CcSEcCtD
Terazosin—Oedema—Capecitabine—stomach cancer	0.000574	0.00123	CcSEcCtD
Terazosin—Dizziness—Irinotecan—stomach cancer	0.000567	0.00121	CcSEcCtD
Terazosin—Jaundice—Doxorubicin—stomach cancer	0.000565	0.00121	CcSEcCtD
Terazosin—Anorexia—Docetaxel—stomach cancer	0.000565	0.00121	CcSEcCtD
Terazosin—Shock—Capecitabine—stomach cancer	0.000564	0.00121	CcSEcCtD
Terazosin—Rhinitis—Epirubicin—stomach cancer	0.000564	0.00121	CcSEcCtD
Terazosin—Conjunctivitis—Doxorubicin—stomach cancer	0.000563	0.00121	CcSEcCtD
Terazosin—Urinary tract infection—Doxorubicin—stomach cancer	0.000563	0.00121	CcSEcCtD
Terazosin—Eye disorder—Methotrexate—stomach cancer	0.000562	0.0012	CcSEcCtD
Terazosin—Diarrhoea—Fluorouracil—stomach cancer	0.000562	0.0012	CcSEcCtD
Terazosin—Thrombocytopenia—Capecitabine—stomach cancer	0.000562	0.0012	CcSEcCtD
Terazosin—Tinnitus—Methotrexate—stomach cancer	0.00056	0.0012	CcSEcCtD
Terazosin—Tachycardia—Capecitabine—stomach cancer	0.00056	0.0012	CcSEcCtD
Terazosin—Pharyngitis—Epirubicin—stomach cancer	0.000558	0.0012	CcSEcCtD
Terazosin—Sweating—Doxorubicin—stomach cancer	0.000556	0.00119	CcSEcCtD
Terazosin—Hyperhidrosis—Capecitabine—stomach cancer	0.000554	0.00119	CcSEcCtD
Terazosin—Oedema peripheral—Epirubicin—stomach cancer	0.000554	0.00119	CcSEcCtD
Terazosin—Hypotension—Docetaxel—stomach cancer	0.000554	0.00119	CcSEcCtD
Terazosin—Epistaxis—Doxorubicin—stomach cancer	0.000547	0.00117	CcSEcCtD
Terazosin—Anorexia—Capecitabine—stomach cancer	0.000547	0.00117	CcSEcCtD
Terazosin—Vomiting—Irinotecan—stomach cancer	0.000545	0.00117	CcSEcCtD
Terazosin—Sinusitis—Doxorubicin—stomach cancer	0.000544	0.00117	CcSEcCtD
Terazosin—Dizziness—Fluorouracil—stomach cancer	0.000543	0.00116	CcSEcCtD
Terazosin—Visual impairment—Epirubicin—stomach cancer	0.000542	0.00116	CcSEcCtD
Terazosin—Rash—Irinotecan—stomach cancer	0.00054	0.00116	CcSEcCtD
Terazosin—Dermatitis—Irinotecan—stomach cancer	0.00054	0.00116	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.00054	0.00116	CcSEcCtD
Terazosin—Headache—Irinotecan—stomach cancer	0.000537	0.00115	CcSEcCtD
Terazosin—Hypotension—Capecitabine—stomach cancer	0.000536	0.00115	CcSEcCtD
Terazosin—Insomnia—Docetaxel—stomach cancer	0.000536	0.00115	CcSEcCtD
Terazosin—Paraesthesia—Docetaxel—stomach cancer	0.000532	0.00114	CcSEcCtD
Terazosin—Dyspnoea—Docetaxel—stomach cancer	0.000528	0.00113	CcSEcCtD
Terazosin—Somnolence—Docetaxel—stomach cancer	0.000527	0.00113	CcSEcCtD
Terazosin—Eye disorder—Epirubicin—stomach cancer	0.000526	0.00113	CcSEcCtD
Terazosin—Tinnitus—Epirubicin—stomach cancer	0.000524	0.00112	CcSEcCtD
Terazosin—Malnutrition—Methotrexate—stomach cancer	0.000523	0.00112	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000523	0.00112	CcSEcCtD
Terazosin—Vomiting—Fluorouracil—stomach cancer	0.000522	0.00112	CcSEcCtD
Terazosin—Rhinitis—Doxorubicin—stomach cancer	0.000522	0.00112	CcSEcCtD
Terazosin—Dyspepsia—Docetaxel—stomach cancer	0.000521	0.00112	CcSEcCtD
Terazosin—Insomnia—Capecitabine—stomach cancer	0.000519	0.00111	CcSEcCtD
Terazosin—Rash—Fluorouracil—stomach cancer	0.000517	0.00111	CcSEcCtD
Terazosin—Dermatitis—Fluorouracil—stomach cancer	0.000517	0.00111	CcSEcCtD
Terazosin—Pharyngitis—Doxorubicin—stomach cancer	0.000516	0.00111	CcSEcCtD
Terazosin—Paraesthesia—Capecitabine—stomach cancer	0.000515	0.0011	CcSEcCtD
Terazosin—Decreased appetite—Docetaxel—stomach cancer	0.000515	0.0011	CcSEcCtD
Terazosin—Headache—Fluorouracil—stomach cancer	0.000514	0.0011	CcSEcCtD
Terazosin—Oedema peripheral—Doxorubicin—stomach cancer	0.000513	0.0011	CcSEcCtD
Terazosin—Dysgeusia—Methotrexate—stomach cancer	0.000512	0.0011	CcSEcCtD
Terazosin—Dyspnoea—Capecitabine—stomach cancer	0.000511	0.0011	CcSEcCtD
Terazosin—Fatigue—Docetaxel—stomach cancer	0.000511	0.00109	CcSEcCtD
Terazosin—Nausea—Irinotecan—stomach cancer	0.000509	0.00109	CcSEcCtD
Terazosin—Pain—Docetaxel—stomach cancer	0.000507	0.00109	CcSEcCtD
Terazosin—Constipation—Docetaxel—stomach cancer	0.000507	0.00109	CcSEcCtD
Terazosin—Back pain—Methotrexate—stomach cancer	0.000506	0.00108	CcSEcCtD
Terazosin—Dyspepsia—Capecitabine—stomach cancer	0.000505	0.00108	CcSEcCtD
Terazosin—Arrhythmia—Epirubicin—stomach cancer	0.000502	0.00108	CcSEcCtD
Terazosin—Visual impairment—Doxorubicin—stomach cancer	0.000501	0.00108	CcSEcCtD
Terazosin—Decreased appetite—Capecitabine—stomach cancer	0.000499	0.00107	CcSEcCtD
Terazosin—Fatigue—Capecitabine—stomach cancer	0.000494	0.00106	CcSEcCtD
Terazosin—Vision blurred—Methotrexate—stomach cancer	0.000493	0.00106	CcSEcCtD
Terazosin—Constipation—Capecitabine—stomach cancer	0.00049	0.00105	CcSEcCtD
Terazosin—Pain—Capecitabine—stomach cancer	0.00049	0.00105	CcSEcCtD
Terazosin—Malnutrition—Epirubicin—stomach cancer	0.00049	0.00105	CcSEcCtD
Terazosin—Feeling abnormal—Docetaxel—stomach cancer	0.000488	0.00105	CcSEcCtD
Terazosin—Nausea—Fluorouracil—stomach cancer	0.000488	0.00105	CcSEcCtD
Terazosin—Eye disorder—Doxorubicin—stomach cancer	0.000486	0.00104	CcSEcCtD
Terazosin—Ill-defined disorder—Methotrexate—stomach cancer	0.000485	0.00104	CcSEcCtD
Terazosin—Tinnitus—Doxorubicin—stomach cancer	0.000485	0.00104	CcSEcCtD
Terazosin—Gastrointestinal pain—Docetaxel—stomach cancer	0.000484	0.00104	CcSEcCtD
Terazosin—Flatulence—Epirubicin—stomach cancer	0.000482	0.00103	CcSEcCtD
Terazosin—Tension—Epirubicin—stomach cancer	0.00048	0.00103	CcSEcCtD
Terazosin—Dysgeusia—Epirubicin—stomach cancer	0.000479	0.00103	CcSEcCtD
Terazosin—Nervousness—Epirubicin—stomach cancer	0.000475	0.00102	CcSEcCtD
Terazosin—Back pain—Epirubicin—stomach cancer	0.000474	0.00102	CcSEcCtD
Terazosin—Feeling abnormal—Capecitabine—stomach cancer	0.000473	0.00101	CcSEcCtD
Terazosin—Malaise—Methotrexate—stomach cancer	0.000472	0.00101	CcSEcCtD
Terazosin—Vertigo—Methotrexate—stomach cancer	0.00047	0.00101	CcSEcCtD
Terazosin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000469	0.00101	CcSEcCtD
Terazosin—Abdominal pain—Docetaxel—stomach cancer	0.000468	0.001	CcSEcCtD
Terazosin—Body temperature increased—Docetaxel—stomach cancer	0.000468	0.001	CcSEcCtD
Terazosin—Arrhythmia—Doxorubicin—stomach cancer	0.000465	0.000997	CcSEcCtD
Terazosin—Vision blurred—Epirubicin—stomach cancer	0.000461	0.000989	CcSEcCtD
Terazosin—Cough—Methotrexate—stomach cancer	0.000456	0.000979	CcSEcCtD
Terazosin—Ill-defined disorder—Epirubicin—stomach cancer	0.000454	0.000974	CcSEcCtD
Terazosin—Body temperature increased—Capecitabine—stomach cancer	0.000453	0.000972	CcSEcCtD
Terazosin—Abdominal pain—Capecitabine—stomach cancer	0.000453	0.000972	CcSEcCtD
Terazosin—Convulsion—Methotrexate—stomach cancer	0.000453	0.000972	CcSEcCtD
Terazosin—Malnutrition—Doxorubicin—stomach cancer	0.000453	0.000971	CcSEcCtD
Terazosin—Flatulence—Doxorubicin—stomach cancer	0.000446	0.000957	CcSEcCtD
Terazosin—Arthralgia—Methotrexate—stomach cancer	0.000445	0.000955	CcSEcCtD
Terazosin—Myalgia—Methotrexate—stomach cancer	0.000445	0.000955	CcSEcCtD
Terazosin—Chest pain—Methotrexate—stomach cancer	0.000445	0.000955	CcSEcCtD
Terazosin—Tension—Doxorubicin—stomach cancer	0.000445	0.000953	CcSEcCtD
Terazosin—Dysgeusia—Doxorubicin—stomach cancer	0.000444	0.000951	CcSEcCtD
Terazosin—Malaise—Epirubicin—stomach cancer	0.000441	0.000946	CcSEcCtD
Terazosin—Discomfort—Methotrexate—stomach cancer	0.00044	0.000943	CcSEcCtD
Terazosin—Nervousness—Doxorubicin—stomach cancer	0.00044	0.000943	CcSEcCtD
Terazosin—Vertigo—Epirubicin—stomach cancer	0.00044	0.000943	CcSEcCtD
Terazosin—Syncope—Epirubicin—stomach cancer	0.000439	0.000941	CcSEcCtD
Terazosin—Back pain—Doxorubicin—stomach cancer	0.000438	0.000939	CcSEcCtD
Terazosin—Hypersensitivity—Docetaxel—stomach cancer	0.000436	0.000936	CcSEcCtD
Terazosin—Palpitations—Epirubicin—stomach cancer	0.000433	0.000927	CcSEcCtD
Terazosin—Confusional state—Methotrexate—stomach cancer	0.00043	0.000923	CcSEcCtD
Terazosin—Loss of consciousness—Epirubicin—stomach cancer	0.00043	0.000922	CcSEcCtD
Terazosin—Cough—Epirubicin—stomach cancer	0.000427	0.000916	CcSEcCtD
Terazosin—Anaphylactic shock—Methotrexate—stomach cancer	0.000427	0.000915	CcSEcCtD
Terazosin—Vision blurred—Doxorubicin—stomach cancer	0.000427	0.000915	CcSEcCtD
Terazosin—Asthenia—Docetaxel—stomach cancer	0.000425	0.000911	CcSEcCtD
Terazosin—Convulsion—Epirubicin—stomach cancer	0.000424	0.000909	CcSEcCtD
Terazosin—Hypersensitivity—Capecitabine—stomach cancer	0.000423	0.000906	CcSEcCtD
Terazosin—Ill-defined disorder—Doxorubicin—stomach cancer	0.00042	0.000901	CcSEcCtD
Terazosin—Pruritus—Docetaxel—stomach cancer	0.000419	0.000898	CcSEcCtD
Terazosin—Thrombocytopenia—Methotrexate—stomach cancer	0.000418	0.000896	CcSEcCtD
Terazosin—Arthralgia—Epirubicin—stomach cancer	0.000417	0.000894	CcSEcCtD
Terazosin—Myalgia—Epirubicin—stomach cancer	0.000417	0.000894	CcSEcCtD
Terazosin—Chest pain—Epirubicin—stomach cancer	0.000417	0.000894	CcSEcCtD
Terazosin—Anxiety—Epirubicin—stomach cancer	0.000415	0.00089	CcSEcCtD
Terazosin—Hyperhidrosis—Methotrexate—stomach cancer	0.000413	0.000885	CcSEcCtD
Terazosin—Discomfort—Epirubicin—stomach cancer	0.000412	0.000883	CcSEcCtD
Terazosin—Asthenia—Capecitabine—stomach cancer	0.000411	0.000882	CcSEcCtD
Terazosin—Malaise—Doxorubicin—stomach cancer	0.000408	0.000876	CcSEcCtD
Terazosin—Dry mouth—Epirubicin—stomach cancer	0.000408	0.000874	CcSEcCtD
Terazosin—Vertigo—Doxorubicin—stomach cancer	0.000407	0.000872	CcSEcCtD
Terazosin—Anorexia—Methotrexate—stomach cancer	0.000407	0.000872	CcSEcCtD
Terazosin—Syncope—Doxorubicin—stomach cancer	0.000406	0.000871	CcSEcCtD
Terazosin—Pruritus—Capecitabine—stomach cancer	0.000406	0.00087	CcSEcCtD
Terazosin—Diarrhoea—Docetaxel—stomach cancer	0.000405	0.000869	CcSEcCtD
Terazosin—Confusional state—Epirubicin—stomach cancer	0.000403	0.000864	CcSEcCtD
Terazosin—Palpitations—Doxorubicin—stomach cancer	0.0004	0.000858	CcSEcCtD
Terazosin—Anaphylactic shock—Epirubicin—stomach cancer	0.0004	0.000857	CcSEcCtD
Terazosin—Oedema—Epirubicin—stomach cancer	0.0004	0.000857	CcSEcCtD
Terazosin—Hypotension—Methotrexate—stomach cancer	0.000399	0.000855	CcSEcCtD
Terazosin—Loss of consciousness—Doxorubicin—stomach cancer	0.000398	0.000854	CcSEcCtD
Terazosin—Cough—Doxorubicin—stomach cancer	0.000395	0.000847	CcSEcCtD
Terazosin—Shock—Epirubicin—stomach cancer	0.000393	0.000843	CcSEcCtD
Terazosin—Convulsion—Doxorubicin—stomach cancer	0.000392	0.000841	CcSEcCtD
Terazosin—Diarrhoea—Capecitabine—stomach cancer	0.000392	0.000841	CcSEcCtD
Terazosin—Dizziness—Docetaxel—stomach cancer	0.000392	0.00084	CcSEcCtD
Terazosin—Thrombocytopenia—Epirubicin—stomach cancer	0.000391	0.000839	CcSEcCtD
Terazosin—Tachycardia—Epirubicin—stomach cancer	0.00039	0.000836	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000389	0.000834	CcSEcCtD
Terazosin—Hyperhidrosis—Epirubicin—stomach cancer	0.000386	0.000828	CcSEcCtD
Terazosin—Insomnia—Methotrexate—stomach cancer	0.000386	0.000828	CcSEcCtD
Terazosin—Chest pain—Doxorubicin—stomach cancer	0.000386	0.000827	CcSEcCtD
Terazosin—Myalgia—Doxorubicin—stomach cancer	0.000386	0.000827	CcSEcCtD
Terazosin—Arthralgia—Doxorubicin—stomach cancer	0.000386	0.000827	CcSEcCtD
Terazosin—Anxiety—Doxorubicin—stomach cancer	0.000384	0.000824	CcSEcCtD
Terazosin—Paraesthesia—Methotrexate—stomach cancer	0.000383	0.000822	CcSEcCtD
Terazosin—Discomfort—Doxorubicin—stomach cancer	0.000381	0.000817	CcSEcCtD
Terazosin—Anorexia—Epirubicin—stomach cancer	0.000381	0.000816	CcSEcCtD
Terazosin—Dyspnoea—Methotrexate—stomach cancer	0.000381	0.000816	CcSEcCtD
Terazosin—Somnolence—Methotrexate—stomach cancer	0.00038	0.000814	CcSEcCtD
Terazosin—Dizziness—Capecitabine—stomach cancer	0.000379	0.000813	CcSEcCtD
Terazosin—Dry mouth—Doxorubicin—stomach cancer	0.000377	0.000809	CcSEcCtD
Terazosin—Vomiting—Docetaxel—stomach cancer	0.000377	0.000807	CcSEcCtD
Terazosin—Dyspepsia—Methotrexate—stomach cancer	0.000376	0.000806	CcSEcCtD
Terazosin—Rash—Docetaxel—stomach cancer	0.000373	0.000801	CcSEcCtD
Terazosin—Hypotension—Epirubicin—stomach cancer	0.000373	0.0008	CcSEcCtD
Terazosin—Dermatitis—Docetaxel—stomach cancer	0.000373	0.0008	CcSEcCtD
Terazosin—Confusional state—Doxorubicin—stomach cancer	0.000373	0.000799	CcSEcCtD
Terazosin—Decreased appetite—Methotrexate—stomach cancer	0.000371	0.000796	CcSEcCtD
Terazosin—Headache—Docetaxel—stomach cancer	0.000371	0.000796	CcSEcCtD
Terazosin—Oedema—Doxorubicin—stomach cancer	0.00037	0.000793	CcSEcCtD
Terazosin—Anaphylactic shock—Doxorubicin—stomach cancer	0.00037	0.000793	CcSEcCtD
Terazosin—Fatigue—Methotrexate—stomach cancer	0.000368	0.000789	CcSEcCtD
Terazosin—Pain—Methotrexate—stomach cancer	0.000365	0.000783	CcSEcCtD
Terazosin—Vomiting—Capecitabine—stomach cancer	0.000365	0.000782	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000364	0.00078	CcSEcCtD
Terazosin—Shock—Doxorubicin—stomach cancer	0.000364	0.00078	CcSEcCtD
Terazosin—Thrombocytopenia—Doxorubicin—stomach cancer	0.000362	0.000776	CcSEcCtD
Terazosin—Rash—Capecitabine—stomach cancer	0.000362	0.000775	CcSEcCtD
Terazosin—Insomnia—Epirubicin—stomach cancer	0.000361	0.000775	CcSEcCtD
Terazosin—Dermatitis—Capecitabine—stomach cancer	0.000361	0.000775	CcSEcCtD
Terazosin—Tachycardia—Doxorubicin—stomach cancer	0.000361	0.000774	CcSEcCtD
Terazosin—Headache—Capecitabine—stomach cancer	0.000359	0.00077	CcSEcCtD
Terazosin—Paraesthesia—Epirubicin—stomach cancer	0.000359	0.000769	CcSEcCtD
Terazosin—Hyperhidrosis—Doxorubicin—stomach cancer	0.000357	0.000766	CcSEcCtD
Terazosin—Dyspnoea—Epirubicin—stomach cancer	0.000356	0.000764	CcSEcCtD
Terazosin—Somnolence—Epirubicin—stomach cancer	0.000355	0.000761	CcSEcCtD
Terazosin—Anorexia—Doxorubicin—stomach cancer	0.000352	0.000755	CcSEcCtD
Terazosin—Nausea—Docetaxel—stomach cancer	0.000352	0.000754	CcSEcCtD
Terazosin—Feeling abnormal—Methotrexate—stomach cancer	0.000352	0.000754	CcSEcCtD
Terazosin—Dyspepsia—Epirubicin—stomach cancer	0.000352	0.000754	CcSEcCtD
Terazosin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000349	0.000748	CcSEcCtD
Terazosin—Decreased appetite—Epirubicin—stomach cancer	0.000347	0.000745	CcSEcCtD
Terazosin—Hypotension—Doxorubicin—stomach cancer	0.000345	0.000741	CcSEcCtD
Terazosin—Fatigue—Epirubicin—stomach cancer	0.000344	0.000738	CcSEcCtD
Terazosin—Pain—Epirubicin—stomach cancer	0.000342	0.000732	CcSEcCtD
Terazosin—Constipation—Epirubicin—stomach cancer	0.000342	0.000732	CcSEcCtD
Terazosin—Nausea—Capecitabine—stomach cancer	0.000341	0.00073	CcSEcCtD
Terazosin—Abdominal pain—Methotrexate—stomach cancer	0.000338	0.000724	CcSEcCtD
Terazosin—Body temperature increased—Methotrexate—stomach cancer	0.000338	0.000724	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000337	0.000722	CcSEcCtD
Terazosin—Insomnia—Doxorubicin—stomach cancer	0.000334	0.000717	CcSEcCtD
Terazosin—Paraesthesia—Doxorubicin—stomach cancer	0.000332	0.000712	CcSEcCtD
Terazosin—Dyspnoea—Doxorubicin—stomach cancer	0.00033	0.000707	CcSEcCtD
Terazosin—Feeling abnormal—Epirubicin—stomach cancer	0.000329	0.000706	CcSEcCtD
Terazosin—Somnolence—Doxorubicin—stomach cancer	0.000329	0.000705	CcSEcCtD
Terazosin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000327	0.0007	CcSEcCtD
Terazosin—Dyspepsia—Doxorubicin—stomach cancer	0.000325	0.000698	CcSEcCtD
Terazosin—Decreased appetite—Doxorubicin—stomach cancer	0.000321	0.000689	CcSEcCtD
Terazosin—Fatigue—Doxorubicin—stomach cancer	0.000319	0.000683	CcSEcCtD
Terazosin—Pain—Doxorubicin—stomach cancer	0.000316	0.000678	CcSEcCtD
Terazosin—Constipation—Doxorubicin—stomach cancer	0.000316	0.000678	CcSEcCtD
Terazosin—Abdominal pain—Epirubicin—stomach cancer	0.000316	0.000677	CcSEcCtD
Terazosin—Body temperature increased—Epirubicin—stomach cancer	0.000316	0.000677	CcSEcCtD
Terazosin—Hypersensitivity—Methotrexate—stomach cancer	0.000315	0.000674	CcSEcCtD
Terazosin—Asthenia—Methotrexate—stomach cancer	0.000306	0.000657	CcSEcCtD
Terazosin—Feeling abnormal—Doxorubicin—stomach cancer	0.000305	0.000653	CcSEcCtD
Terazosin—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000302	0.000648	CcSEcCtD
Terazosin—Pruritus—Methotrexate—stomach cancer	0.000302	0.000648	CcSEcCtD
Terazosin—Hypersensitivity—Epirubicin—stomach cancer	0.000294	0.000631	CcSEcCtD
Terazosin—Body temperature increased—Doxorubicin—stomach cancer	0.000292	0.000627	CcSEcCtD
Terazosin—Abdominal pain—Doxorubicin—stomach cancer	0.000292	0.000627	CcSEcCtD
Terazosin—Diarrhoea—Methotrexate—stomach cancer	0.000292	0.000626	CcSEcCtD
Terazosin—Asthenia—Epirubicin—stomach cancer	0.000287	0.000615	CcSEcCtD
Terazosin—Pruritus—Epirubicin—stomach cancer	0.000283	0.000606	CcSEcCtD
Terazosin—Dizziness—Methotrexate—stomach cancer	0.000282	0.000605	CcSEcCtD
Terazosin—Diarrhoea—Epirubicin—stomach cancer	0.000273	0.000586	CcSEcCtD
Terazosin—Hypersensitivity—Doxorubicin—stomach cancer	0.000272	0.000584	CcSEcCtD
Terazosin—Vomiting—Methotrexate—stomach cancer	0.000271	0.000582	CcSEcCtD
Terazosin—Rash—Methotrexate—stomach cancer	0.000269	0.000577	CcSEcCtD
Terazosin—Dermatitis—Methotrexate—stomach cancer	0.000269	0.000577	CcSEcCtD
Terazosin—Headache—Methotrexate—stomach cancer	0.000267	0.000573	CcSEcCtD
Terazosin—Asthenia—Doxorubicin—stomach cancer	0.000265	0.000569	CcSEcCtD
Terazosin—Dizziness—Epirubicin—stomach cancer	0.000264	0.000566	CcSEcCtD
Terazosin—Pruritus—Doxorubicin—stomach cancer	0.000262	0.000561	CcSEcCtD
Terazosin—Vomiting—Epirubicin—stomach cancer	0.000254	0.000545	CcSEcCtD
Terazosin—Nausea—Methotrexate—stomach cancer	0.000254	0.000544	CcSEcCtD
Terazosin—Diarrhoea—Doxorubicin—stomach cancer	0.000253	0.000542	CcSEcCtD
Terazosin—Rash—Epirubicin—stomach cancer	0.000252	0.00054	CcSEcCtD
Terazosin—Dermatitis—Epirubicin—stomach cancer	0.000252	0.00054	CcSEcCtD
Terazosin—Headache—Epirubicin—stomach cancer	0.00025	0.000537	CcSEcCtD
Terazosin—Dizziness—Doxorubicin—stomach cancer	0.000244	0.000524	CcSEcCtD
Terazosin—Nausea—Epirubicin—stomach cancer	0.000237	0.000509	CcSEcCtD
Terazosin—Vomiting—Doxorubicin—stomach cancer	0.000235	0.000504	CcSEcCtD
Terazosin—Rash—Doxorubicin—stomach cancer	0.000233	0.0005	CcSEcCtD
Terazosin—Dermatitis—Doxorubicin—stomach cancer	0.000233	0.000499	CcSEcCtD
Terazosin—Headache—Doxorubicin—stomach cancer	0.000232	0.000497	CcSEcCtD
Terazosin—Nausea—Doxorubicin—stomach cancer	0.00022	0.000471	CcSEcCtD
Terazosin—ADRA1B—Signaling by GPCR—ADRB2—stomach cancer	5.54e-05	0.000379	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PGAM1—stomach cancer	5.52e-05	0.000378	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NT5E—stomach cancer	5.52e-05	0.000378	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FST—stomach cancer	5.45e-05	0.000373	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PPP2R1A—stomach cancer	5.43e-05	0.000372	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	5.42e-05	0.000372	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—ADRB2—stomach cancer	5.42e-05	0.000371	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HSPB1—stomach cancer	5.4e-05	0.00037	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AGTR2—stomach cancer	5.4e-05	0.00037	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	5.4e-05	0.00037	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PRKAA1—stomach cancer	5.4e-05	0.00037	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	5.39e-05	0.000369	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—BMP2—stomach cancer	5.34e-05	0.000366	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—F2R—stomach cancer	5.34e-05	0.000366	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HBEGF—stomach cancer	5.33e-05	0.000365	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PLCE1—stomach cancer	5.27e-05	0.000361	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALDH7A1—stomach cancer	5.27e-05	0.000361	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKR1C3—stomach cancer	5.26e-05	0.00036	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RGS2—stomach cancer	5.26e-05	0.00036	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GAST—stomach cancer	5.26e-05	0.00036	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	5.23e-05	0.000358	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RBP4—stomach cancer	5.22e-05	0.000357	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—CXCL8—stomach cancer	5.21e-05	0.000357	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	5.21e-05	0.000357	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR1A—stomach cancer	5.2e-05	0.000356	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	5.19e-05	0.000356	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	5.1e-05	0.000349	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—UMPS—stomach cancer	5.05e-05	0.000346	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PRKCB—stomach cancer	5.04e-05	0.000345	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ANXA1—stomach cancer	5.02e-05	0.000344	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FGG—stomach cancer	4.98e-05	0.000341	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—ADRB2—stomach cancer	4.92e-05	0.000337	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ADRB1—stomach cancer	4.86e-05	0.000333	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PPP2R1A—stomach cancer	4.82e-05	0.00033	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	4.82e-05	0.00033	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRKAA1—stomach cancer	4.8e-05	0.000328	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	4.71e-05	0.000323	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PDHA1—stomach cancer	4.7e-05	0.000322	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ECHS1—stomach cancer	4.7e-05	0.000322	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RPS6—stomach cancer	4.65e-05	0.000318	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RBP4—stomach cancer	4.63e-05	0.000317	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CXCL8—stomach cancer	4.63e-05	0.000317	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	4.61e-05	0.000316	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PRKCB—stomach cancer	4.57e-05	0.000313	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL6ST—stomach cancer	4.55e-05	0.000312	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	4.52e-05	0.00031	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AGTR2—stomach cancer	4.48e-05	0.000307	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HSPB1—stomach cancer	4.48e-05	0.000307	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	4.46e-05	0.000305	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—BMP2—stomach cancer	4.43e-05	0.000304	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—F2R—stomach cancer	4.43e-05	0.000304	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—TYMP—stomach cancer	4.42e-05	0.000302	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—FADS1—stomach cancer	4.42e-05	0.000302	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKR1C3—stomach cancer	4.36e-05	0.000299	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	4.33e-05	0.000297	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR1A—stomach cancer	4.32e-05	0.000296	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HBEGF—stomach cancer	4.27e-05	0.000293	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	4.24e-05	0.00029	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	4.24e-05	0.00029	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PRKCB—stomach cancer	4.18e-05	0.000286	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ANXA1—stomach cancer	4.17e-05	0.000286	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SREBF2—stomach cancer	4.13e-05	0.000283	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—RORA—stomach cancer	4.09e-05	0.00028	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL6R—stomach cancer	4.06e-05	0.000278	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—RHOA—stomach cancer	4.04e-05	0.000277	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADRB1—stomach cancer	4.04e-05	0.000277	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	4.04e-05	0.000276	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	4e-05	0.000274	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AGTR2—stomach cancer	3.98e-05	0.000273	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HSPB1—stomach cancer	3.98e-05	0.000273	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ADRB2—stomach cancer	3.94e-05	0.00027	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—F2R—stomach cancer	3.94e-05	0.00027	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—BMP2—stomach cancer	3.94e-05	0.00027	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKR1C3—stomach cancer	3.87e-05	0.000265	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PPP2R1A—stomach cancer	3.86e-05	0.000265	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RPS6—stomach cancer	3.86e-05	0.000264	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR1A—stomach cancer	3.83e-05	0.000263	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALDOB—stomach cancer	3.83e-05	0.000262	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PRKCB—stomach cancer	3.8e-05	0.00026	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6ST—stomach cancer	3.78e-05	0.000259	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PRKCB—stomach cancer	3.71e-05	0.000254	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ANXA1—stomach cancer	3.7e-05	0.000254	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	3.68e-05	0.000252	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—RHOA—stomach cancer	3.67e-05	0.000251	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SMAD4—stomach cancer	3.59e-05	0.000246	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADRB1—stomach cancer	3.59e-05	0.000246	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALOX5—stomach cancer	3.56e-05	0.000244	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.56e-05	0.000244	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CXCL8—stomach cancer	3.55e-05	0.000243	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HBEGF—stomach cancer	3.54e-05	0.000243	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—DPYD—stomach cancer	3.5e-05	0.00024	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RPS6—stomach cancer	3.43e-05	0.000235	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	3.42e-05	0.000235	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FYN—stomach cancer	3.41e-05	0.000233	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6R—stomach cancer	3.37e-05	0.000231	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PRKCB—stomach cancer	3.37e-05	0.000231	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6ST—stomach cancer	3.36e-05	0.00023	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—RHOA—stomach cancer	3.36e-05	0.00023	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADRB2—stomach cancer	3.27e-05	0.000224	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CXCL8—stomach cancer	3.22e-05	0.000221	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PPP2R1A—stomach cancer	3.21e-05	0.00022	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FGFR2—stomach cancer	3.2e-05	0.000219	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HBEGF—stomach cancer	3.15e-05	0.000216	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTT1—stomach cancer	3.1e-05	0.000212	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP2A6—stomach cancer	3.06e-05	0.00021	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—RHOA—stomach cancer	3.05e-05	0.000209	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6R—stomach cancer	3e-05	0.000205	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—RHOA—stomach cancer	2.98e-05	0.000204	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AKR1C3—stomach cancer	2.98e-05	0.000204	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SMAD4—stomach cancer	2.98e-05	0.000204	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CXCL8—stomach cancer	2.95e-05	0.000202	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IRS2—stomach cancer	2.93e-05	0.0002	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADRB2—stomach cancer	2.91e-05	0.000199	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ENO1—stomach cancer	2.9e-05	0.000199	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PPP2R1A—stomach cancer	2.85e-05	0.000195	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CAV1—stomach cancer	2.84e-05	0.000194	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOA1—stomach cancer	2.83e-05	0.000194	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FYN—stomach cancer	2.83e-05	0.000194	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	2.71e-05	0.000186	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—RHOA—stomach cancer	2.71e-05	0.000185	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PRKCB—stomach cancer	2.7e-05	0.000185	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6ST—stomach cancer	2.69e-05	0.000184	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CXCL8—stomach cancer	2.67e-05	0.000183	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FGFR2—stomach cancer	2.65e-05	0.000182	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SMAD4—stomach cancer	2.64e-05	0.000181	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CXCL8—stomach cancer	2.62e-05	0.000179	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APC—stomach cancer	2.59e-05	0.000177	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CD44—stomach cancer	2.57e-05	0.000176	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FYN—stomach cancer	2.51e-05	0.000172	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—MAPK3—stomach cancer	2.48e-05	0.00017	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IRS2—stomach cancer	2.43e-05	0.000166	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6R—stomach cancer	2.4e-05	0.000164	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CXCL8—stomach cancer	2.38e-05	0.000163	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FGFR2—stomach cancer	2.36e-05	0.000161	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—MAPK1—stomach cancer	2.36e-05	0.000161	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CAV1—stomach cancer	2.36e-05	0.000161	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—EGFR—stomach cancer	2.36e-05	0.000161	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOA1—stomach cancer	2.35e-05	0.000161	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PIK3CA—stomach cancer	2.25e-05	0.000154	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SERPINE1—stomach cancer	2.25e-05	0.000154	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PRKCB—stomach cancer	2.24e-05	0.000154	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6ST—stomach cancer	2.23e-05	0.000153	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—KRAS—stomach cancer	2.23e-05	0.000152	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPP2R1A—stomach cancer	2.19e-05	0.00015	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RHOA—stomach cancer	2.17e-05	0.000149	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IRS2—stomach cancer	2.16e-05	0.000148	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTP1—stomach cancer	2.15e-05	0.000147	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NOS3—stomach cancer	2.15e-05	0.000147	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APC—stomach cancer	2.15e-05	0.000147	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HMOX1—stomach cancer	2.12e-05	0.000145	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CAV1—stomach cancer	2.09e-05	0.000143	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOA1—stomach cancer	2.09e-05	0.000143	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—MAPK3—stomach cancer	2.06e-05	0.000141	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CA—stomach cancer	2.04e-05	0.00014	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ERBB2—stomach cancer	2.01e-05	0.000137	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—TYMS—stomach cancer	2e-05	0.000137	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6R—stomach cancer	1.99e-05	0.000136	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRKCB—stomach cancer	1.99e-05	0.000136	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6ST—stomach cancer	1.98e-05	0.000136	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTM1—stomach cancer	1.97e-05	0.000135	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—MAPK1—stomach cancer	1.96e-05	0.000134	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—EGFR—stomach cancer	1.95e-05	0.000134	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APC—stomach cancer	1.91e-05	0.000131	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CXCL8—stomach cancer	1.9e-05	0.00013	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HRAS—stomach cancer	1.89e-05	0.00013	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CA—stomach cancer	1.87e-05	0.000128	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SERPINE1—stomach cancer	1.87e-05	0.000128	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CDKN1B—stomach cancer	1.86e-05	0.000127	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ERCC2—stomach cancer	1.85e-05	0.000127	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—KRAS—stomach cancer	1.85e-05	0.000126	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—MAPK3—stomach cancer	1.83e-05	0.000125	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL6—stomach cancer	1.81e-05	0.000124	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RHOA—stomach cancer	1.8e-05	0.000123	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOS3—stomach cancer	1.78e-05	0.000122	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCND1—stomach cancer	1.77e-05	0.000121	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6R—stomach cancer	1.77e-05	0.000121	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—JUN—stomach cancer	1.77e-05	0.000121	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—MTHFR—stomach cancer	1.74e-05	0.000119	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	1.74e-05	0.000119	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	1.74e-05	0.000119	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MMP9—stomach cancer	1.72e-05	0.000118	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CDKN1A—stomach cancer	1.72e-05	0.000118	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CA—stomach cancer	1.7e-05	0.000116	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MAPK8—stomach cancer	1.67e-05	0.000115	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ERBB2—stomach cancer	1.67e-05	0.000114	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	1.66e-05	0.000114	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	1.66e-05	0.000114	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	1.64e-05	0.000112	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CAV1—stomach cancer	1.61e-05	0.00011	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOA1—stomach cancer	1.6e-05	0.00011	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RHOA—stomach cancer	1.6e-05	0.000109	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOS3—stomach cancer	1.58e-05	0.000108	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCL8—stomach cancer	1.58e-05	0.000108	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HRAS—stomach cancer	1.57e-05	0.000108	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—VEGFA—stomach cancer	1.55e-05	0.000106	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CDKN1B—stomach cancer	1.54e-05	0.000106	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—STAT3—stomach cancer	1.53e-05	0.000105	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	1.51e-05	0.000103	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6—stomach cancer	1.5e-05	0.000103	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	1.48e-05	0.000101	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCND1—stomach cancer	1.47e-05	0.000101	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—JUN—stomach cancer	1.47e-05	0.000101	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MAPK3—stomach cancer	1.46e-05	0.0001	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MMP9—stomach cancer	1.43e-05	9.79e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	1.42e-05	9.75e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MYC—stomach cancer	1.42e-05	9.74e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPARG—stomach cancer	1.41e-05	9.68e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	1.4e-05	9.61e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	1.39e-05	9.55e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MAPK1—stomach cancer	1.39e-05	9.53e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EGFR—stomach cancer	1.39e-05	9.53e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	1.39e-05	9.52e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	1.37e-05	9.39e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6—stomach cancer	1.33e-05	9.14e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—KRAS—stomach cancer	1.31e-05	9e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCND1—stomach cancer	1.31e-05	8.96e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—JUN—stomach cancer	1.3e-05	8.94e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	1.28e-05	8.79e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALB—stomach cancer	1.27e-05	8.7e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—STAT3—stomach cancer	1.27e-05	8.7e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MMP9—stomach cancer	1.27e-05	8.69e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	1.26e-05	8.66e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	1.23e-05	8.46e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NOS3—stomach cancer	1.22e-05	8.33e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	1.21e-05	8.31e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	1.21e-05	8.27e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MYC—stomach cancer	1.18e-05	8.09e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TP53—stomach cancer	1.17e-05	8e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	1.16e-05	7.91e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EGFR—stomach cancer	1.15e-05	7.91e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	1.14e-05	7.81e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—STAT3—stomach cancer	1.13e-05	7.73e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HRAS—stomach cancer	1.12e-05	7.65e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS2—stomach cancer	1.11e-05	7.62e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—KRAS—stomach cancer	1.09e-05	7.47e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	1.08e-05	7.39e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6—stomach cancer	1.07e-05	7.32e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MYC—stomach cancer	1.05e-05	7.18e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	1.03e-05	7.03e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EGFR—stomach cancer	1.03e-05	7.03e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	1e-05	6.86e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TP53—stomach cancer	9.7e-06	6.64e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KRAS—stomach cancer	9.69e-06	6.64e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HRAS—stomach cancer	9.27e-06	6.35e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	8.9e-06	6.1e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6—stomach cancer	8.88e-06	6.08e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TP53—stomach cancer	8.61e-06	5.9e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HRAS—stomach cancer	8.24e-06	5.64e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6—stomach cancer	7.88e-06	5.4e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CA—stomach cancer	6.84e-06	4.69e-05	CbGpPWpGaD
